U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
179641179641Autologous Stem Cells for Cardiac Angiogenesis (FOCUS HF)CompletedHas ResultsIschemic CardiomyopathyDevice: Intramyocardial Injection of stem cells via NOGA Mapping|Other: Control, then Stem Cell Therapyhttps://ClinicalTrials.gov/show/NCT00203203
179642179642A Double-Blind, Placebo-Controlled Study Examining the Use of Topiramate in the Treatment of Cluster HeadacheTerminatedNo Results AvailableCluster HeadacheDrug: Topiramatehttps://ClinicalTrials.gov/show/NCT00203190
179643179643Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.CompletedNo Results AvailableParkinson's DiseaseDrug: rasagiline mesylate|Drug: rasagiline mesylate 1.0 mghttps://ClinicalTrials.gov/show/NCT00203177
179644179644Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease PatientsCompletedNo Results AvailableParkinson's DiseaseDrug: rasagiline mesylatehttps://ClinicalTrials.gov/show/NCT00203164
179645179645A Study to Evaluate the Tolerability, Safety and Effectiveness of Edratide in the Treatment of LupusTerminatedNo Results AvailableSystemic Lupus ErythematosusDrug: edratidehttps://ClinicalTrials.gov/show/NCT00203151
179646179646Safety, Tolerability, and Effectiveness of Rasagiline Mesylate in Patients With Parkinson's DiseaseCompletedNo Results AvailableParkinson's DiseaseDrug: rasagiline mesylatehttps://ClinicalTrials.gov/show/NCT00203138
179647179647A Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study.CompletedNo Results AvailableParkinson's DiseaseDrug: rasagiline mesylate|Other: tyraminehttps://ClinicalTrials.gov/show/NCT00203125
179648179648Safety and Efficacy Study of Copaxone Administered in Combination With MinocyclineCompletedNo Results AvailableRelapse Remitting Multiple SclerosisDrug: glatiramer acetate with minocycline|Drug: Glatiramer acetate with placebohttps://ClinicalTrials.gov/show/NCT00203112
179649179649Safety and Efficacy Study of Copaxone Administered in Combination With N-AcetylcysteineCompletedNo Results AvailableRelapse Remitting Multiple SclerosisDrug: Glatiramer Acetate, N-Acetylcysteinehttps://ClinicalTrials.gov/show/NCT00203099
179650179650A Study to Evaluate the Long Term Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple SclerosisCompletedNo Results AvailableRelapsing Remitting Multiple Sclerosishttps://ClinicalTrials.gov/show/NCT00203086
179651179651A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis.CompletedNo Results AvailableRelapsing Remitting Multiple SclerosisDrug: glatiramer acetate 20 mg|Drug: glatiramer acetate 20 mg, with mitoxantronehttps://ClinicalTrials.gov/show/NCT00203073
179652179652Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With LevodopaCompletedNo Results AvailableParkinson's DiseaseDrug: Rasagiline Mesylate|Drug: placebohttps://ClinicalTrials.gov/show/NCT00203060
179653179653Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer AcetateTerminatedHas ResultsRelapsing Remitting Multiple SclerosisDrug: Glatiramer Acetate|Drug: Placebo|Drug: Prednisonehttps://ClinicalTrials.gov/show/NCT00203047
179654179654Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor FluctuationsCompletedNo Results AvailableParkinson's DiseaseDrug: rasagiline mesylate|Drug: 1.0 mg rasagiline mesylate|Other: Placebohttps://ClinicalTrials.gov/show/NCT00203034
179655179655Copaxone® Study to Follow Patients From the First Original Study for Safety and Effectiveness.Active, not recruitingNo Results AvailableMultiple SclerosisDrug: Glatiramer acetatehttps://ClinicalTrials.gov/show/NCT00203021
179656179656A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of MelanomaCompletedNo Results AvailableParkinson's Disease|Malignant Melanomahttps://ClinicalTrials.gov/show/NCT00203008
179657179657Randomized Study Designed to Look at Disease Progression Using 2 Currently FDA Approved Drugs for the Treatment of RRMSTerminatedNo Results AvailableRelapsing Remitting Multiple SclerosisDrug: Glatiramer Acetate|Drug: Betaseron|Drug: Rebifhttps://ClinicalTrials.gov/show/NCT00202995
179658179658A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved DoseCompletedNo Results AvailableRelapse-Remitting Multiple SclerosisDrug: glatiramer acetate 20 mg|Drug: glatiramer acetate 40 mghttps://ClinicalTrials.gov/show/NCT00202982
179659179659Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric CancerCompletedNo Results AvailableGastric CancerDrug: S-1|Drug: S-1 plus CDDP|Drug: 5-FU plus CDDPhttps://ClinicalTrials.gov/show/NCT00202969
179660179660Safety and Efficacy Study of Bugusan (BGS)to Treat Osteoporosis.RecruitingNo Results AvailableOsteoporosisDrug: Bugusanhttps://ClinicalTrials.gov/show/NCT00202956
179661179661Randomized Controlled Trial of TCRFVR and LAUP in SnorersCompletedNo Results AvailableSnorerProcedure: TCRFVR and LAUPhttps://ClinicalTrials.gov/show/NCT00202943
179662179662Use of Rituximab in Opsoclonus-Myoclonus in Children With NeuroblastomaRecruitingNo Results AvailableNeuroblastoma|Opsoclonus-MyoclonusDrug: anti-CD20 (Rituximab)https://ClinicalTrials.gov/show/NCT00202930
179663179663Haploidentical Transplantation With CD3/CD19 Depleted Grafts in Patients With Hematologic MalignanciesCompletedNo Results AvailableHematologic MalignanciesDrug: Fludarabine|Drug: Thiotepa|Drug: Melphalan|Drug: OKT-3|Procedure: CD3/CD19 depletion on CliniMACShttps://ClinicalTrials.gov/show/NCT00202917
179664179664Effectiveness and Safety of Ezetimibe Added to Atorvastatin in Patients With High Cholesterol and Coronary Heart Disease (Study P03740)CompletedNo Results AvailableHypercholesterolemia|Coronary Heart DiseaseDrug: ezetimibe|Drug: placebohttps://ClinicalTrials.gov/show/NCT00202904
179665179665Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas (Study P04460)WithdrawnNo Results AvailablePyodermaDrug: sisomicinhttps://ClinicalTrials.gov/show/NCT00202891
179666179666IMPROVE-IT: Examining Outcomes in Subjects With Acute Coronary Syndrome: Vytorin (Ezetimibe/Simvastatin) vs Simvastatin (P04103)CompletedNo Results AvailableHypercholesterolemia|Myocardial InfarctionDrug: ezetimibe/simvastatin|Drug: simvastatinhttps://ClinicalTrials.gov/show/NCT00202878
179667179667Evaluation of Low Dose Infliximab in Ankylosing Spondylitis (Study P04352)CompletedNo Results AvailableSpondylitis, AnkylosingBiological: infliximab|Biological: Placebohttps://ClinicalTrials.gov/show/NCT00202865
179668179668A Placebo-Controlled, Double-Blinded, Randomized Trial of Remicade in Korean Patients With Rheumatoid Arthritis Despite Methotrexate (Study P04280)(COMPLETED)CompletedNo Results AvailableArthritis, RheumatoidOther: Placebo|Drug: MTX|Biological: Infliximab|Drug: MTXhttps://ClinicalTrials.gov/show/NCT00202852
179669179669Peg-Intron/Ribavirin in G 1 HCV for Non-Extended Versus 24 Week Extended Treatment After 24 Weeks (Study P04144)(COMPLETED)CompletedHas ResultsHepatitis C, ChronicBiological: PegIntron (peginterferon alfa-2b; SCH 54031)|Biological: PegIntron (peginterferon alfa-2b; SCH 54031)|Drug: Ribavirin|Drug: Ribavirinhttps://ClinicalTrials.gov/show/NCT00202839
179670179670Study of Fluid Collection of the Chest in Children With PneumoniaCompletedNo Results AvailableCommunity Acquired Bacterial Pneumonia|Paraneumonic EffusionProcedure: Video Assisted Thorascopic Surgery Thoracostomy Tube Placement & Drainagehttps://ClinicalTrials.gov/show/NCT00202826

* Görseller ve İçerik tekif hakkına sahip olabilir